Evaluation of Serum Leucine‐Rich Alpha‐2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
Tetsuhiro Yoshimura(Kurume University), Takuji Torimura(Omuta hospital), Shuhei Fukunaga(Kurume University), Keiichi Mitsuyama(Kurume University), Hidetoshi Takedatsu(Kurume University), Kozo Tsuruta(Kurume University), Shinichiro Yoshioka(Kurume University), Atsushi Mori(Kurume University), Masaru Morita(Kurume University), Hiroshi Yamasaki(Kurume University), Kotaro Kuwaki(Kurume University), Toshihiro Araki(Kurume University), Ryosuke Sakemi(Kyushu Kyoritsu University)
Cited by 36
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410